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Background: Viral upper respiratory tract infections are associated with increased colonization by Streptococcus
pneumoniae but the mechanisms underlying this relationship are unclear. The objective of this study is to describe
a comprehensive picture of the cellular interaction between the adhering bacteria and host cells in the presence or
absence of a viral co-infection.
Results: Gene expression profiles of Detroit-562 pharyngeal cells, which were either mock-infected or infected with
human respiratory syncytial virus (RSV) or human parainfluenza virus 3 (HPIV3), were analyzed using human
microarrays. Transcription response of S. pneumoniae strain TIGR4 (serotype 4) in the presence of either mock- or
viral-infected cells was analyzed by pneumococcal microarray. Significantly regulated genes were identified by both
significance analysis of microarray (SAM) and a ≥ 2-fold change ratio cut-off. The adherence of S. pneumoniae to
human pharyngeal cells was significantly augmented in the presence of RSV or HPIV3 infection. Global gene expression
profiling of the host cells during infection with RSV or HPIV3 revealed increased transcription of carcinoembryonic
antigen-related cell adhesion molecules (CEACAM1), CD47, fibronectin, interferon-stimulated genes and many other
host cell adhesion molecules. Pneumococci increased transcription of several genes involved in adhesive functions
(psaA, pilus islet), choline uptake and incorporation (lic operon), as well as transport and binding.
Conclusions: We have identified a core transcriptome that represents the basic machinery required for adherence of
pneumococci to D562 cells infected or not infected with a virus. These bacterial genes and cell adhesion molecules
can potentially be used to control pneumococcal adherence occurring secondary to a viral infection.
Keywords: Streptococcus pneumoniae, RSV, HPIV3, Gene expression, Microarray, Adherence, Bacterial-viral co-infectionBackground
Viruses play a pivotal role in modulating host cells, conse-
quently mediating bacterial superinfection [1-8]. However,
the mechanisms responsible for promoting bacterial super-
infection are poorly understood. There are two potential
explanations: (a) the virus changes the structure of the re-
spiratory tract, paving the way for bacterial pathogens
[1,9-12]; or (b) the virus alters the host’s innate immune* Correspondence: tettelin@som.umaryland.edu
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distribution, and reproduction in any mediumresponse, making it more susceptible to bacterial infec-
tions [13-17].
Although several studies have demonstrated suppression
of the host’s immune response as a potential mechanism
for bacterial superinfection, the degree of bacterial infec-
tion induced by prior viral infection is indistinguishable
from that shown using experimental models without a
complete immune system e.g. in vitro adhesion assays.
This suggests separate or additional mechanisms of ac-
tion that are independent of immune mechanisms.
Studies of polymicrobial interactions have revealed that
cellular receptors such as CD14, CD15, CD18, carcinoem-
bryonic antigen-related cell adhesion molecule (CEACAM),Central Ltd. This is an Open Access article distributed under the terms of the
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(PAFR), fibronectin (FN) and fimbriae-associated recep-
tors are likely to be involved in increased bacterial
adherence after viral infection [9,11,14,18-21]. Given the
diversity of host receptors, this list of adhesion molecules
is unlikely to be exhaustive. Only a few studies have exam-
ined the local surface remodeling of human pharyngeal
cells by viruses despite the fact that they are the portal
of entry for both viruses and bacteria. The full range of
adhesion molecules that can be up-regulated during a
respiratory viral infection and facilitate bacterial attach-
ment and entry is still unknown.
Some studies suggest that bacterial factors also play a
part in this interaction, but whether or not bacteria
modulate their surface structures to enhance adherence
in the presence of viral infection remains controversial
[19,22-24]. Several pneumococcal adhesins have been de-
scribed [25-27] but their significance in virus-enhanced
adherence has not been studied. PspA is the only
pneumococcal virulence factor that has been shown to
contribute to secondary pneumococcal infections after
viral infection [22]. We sought to examine the genes
expressed by Streptococcus pneumoniae when in contact
with virus-infected cells in order to facilitate the design
of vaccine and therapeutic targets to control bacterial
adherence during polymicrobial infections. We used
DNA microarrays to obtain a comprehensive view of:
(a) the responses of human pharyngeal cells to infection
with respiratory syncytial virus (RSV) and human para-
influenza virus type 3 (HPIV3) and (b) the effect that
the viral infection has on both attachment and gene
regulation of the pneumococcus.
Methods
Bacterial and viral strains and cell lines
TIGR4 [28] and G54 [29] pneumococcal strains, respira-
tory syncytial virus (RSV) strain ch 93-18b and human
parainfluenza virus 3 (HPIV3) strain C243 were used in
this study. The RSV strain was originally obtained from
the University of Rochester Medical Center and the
HPIV3 strain originated from the CDC respiratory reposi-
tory. Pharyngeal human carcinoma epithelial cells (Detroit
562, CCL138) were obtained from ATCC (Rockville, MD,
USA) and were grown and maintained as previously de-
scribed [26].
Viral infection scheme and adherence assay
Tissue culture microtiter plates were seeded with 200 μl
of a 2 × 105 D562 cells/ml suspension per well and grown
for ~4 d to about 80% confluence (9.6 × 104 cells/well).
Semi-confluent monolayers were washed twice with phos-
phate buffered saline (PBS) and inoculated with a 100 μl
volume of viral suspension. To infect monolayers with
RSV, the virus stock containing 6.5 × 106 TCID50/ml wasdiluted to 10-1 to 10-3 with minimal essential medium with
Eagle's salts (EMEM) (Gibco Laboratories, Grand Island,
NY, USA), supplemented with penicillin (50 μg/ml),
streptomycin (50 μg/ml) and 2% fetal bovine serum (FBS)
(Hyclone, Logan, UT, USA). Each dilution of the virus was
inoculated in triplicate. For HPIV3, the virus stock
containing 8.3 × 107 TCID50/ml was diluted to 10
-3 to
10-6 with serum-free EMEM containing penicillin (100
μg/ml), streptomycin (100 μg/ml) and supplemented
with crystallized porcine trypsin. Each virus dilution
was inoculated into six wells. The negative control,
which constituted of the same culture medium used for
viral inoculation but without the virus, was seeded in
another six wells. Plates were incubated at 37°C in a 5%
CO2 incubator and, at 24 h intervals after inoculation
(24–72 h for RSV and 24–120 h for HPIV3), were used
for pneumococcal adherence experiments as previously
described [26]. Briefly, monolayers were washed once
with 125 μl/well of EMEM without L-glutamine and
supplemented with 7% FBS (Atlas Biologicals, Fort
Collins, CO). To the washed monolayer of each well, 80
μl of EMEM was added, followed by 20 μl/well of bac-
terial suspension (103 bacteria/well). The final D562 cell
yield was 1.2 × 105 cells/well after 6 days of incubation
resulting in an MOI of 0.01. Plates were incubated for
2 h at 37°C in a 5% CO2 incubator to allow for adherence
then washed 5 X with PBS with 0.2% bovine serum albu-
min (BSA) to remove non-adherent pneumococci. A 65 ml
volume of Todd-Hewitt broth supplemented with 0.5%
yeast extract (THYE), 0.8% agar, and 0.1% 2,3,5-triphenyl
tetrazolium chloride (TTC; Difco Laboratories), was added
and the plates were incubated overnight at 37°C in a 5%
CO2 incubator. The number of colonies of S. pneumoniae
adhering to D562 cells was counted using an automated
colony counter (AlphaImager; Alpha Innotech, CA). Ad-
herence to both mock-infected cells (medium with
no virus) and virus-infected cells was expressed as the
mean (± standard error of the mean, SEM) number of
colony forming units (CFUs) in at least 3 replicate
wells. Differences in adherence between virus- and mock-
infected cells were tested by Student’s t-test (p < 0.05). RSV
or HPIV3 growth was detected and monitored by the use
of an indirect immunofluorescence assay (Light Diagnos-
tics Respiratory Viral Screen IFA, Millipore Corporation,
Billerica, MA).
It is worth noting that although the adherence assays
in this and in the accompanying manuscript by Kimaro
Mlacha et al. were performed the same way, there was
one difference in the treatment of mock-infected D562
cells (cells not infected with viruses) prior to the adherence
assay. For this manuscript, the D562 cells were manipu-
lated before reaching 100% confluence. At day 4, cells were
washed to allow for viral inoculation. This manipulation of
the monolayer might have resulted in fewer D562 cells
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companying manuscript, which were left intact for
6 days. Despite this difference, the mock-infected and
virus-infected cells within the assay described in this
manuscript were treated exactly the same way, making
the comparison relevant within this experiment.
For microarray experiments, semi-confluent D562 cells
grown in tissue culture flasks were either mock-infected
or infected with stock virus at 6.5 × 105 TCID50 /ml for
RSV and 8.3 × 103 TCID50/ml for HPIV3, and incubated
at 37°C on a shaker. After 1 h of adsorption, fresh medium
was added into each flask and cultures were incubated
at 37°C for 3 d. The D562 cells were used for: (a)
pneumococcal microarray experiments or (b) analysis of
host-cell transcription profiles upon exposure to RSV or
HPIV3. (a) Virus-infected and mock-infected cells were
inoculated with 1 ml of pneumococcal TIGR4 strain
containing 107 bacteria and incubated for 2 h at 37°C in
a 5% CO2 incubator. Non-adherent bacteria (contained
in the spent cell culture medium) were removed and
cells were washed 3X with PBS and then treated immedi-
ately with 10 ml of RNAprotect (Qiagen, Valencia, CA,
USA). Adherent bacteria were dissociated from host cells
by lysis with 0.1% (w/v) saponin in PBS followed by sonic-
ation using 5 s pulses for 1 min. Bacteria were subse-
quently harvested by differential centrifugation. Control
bacteria, which were not exposed to host cells, were
suspended in EMEM medium and then prepared in par-
allel and treated identically to adherent bacteria. Pellets
were stored at −80°C. (b) After inoculation of semi-
confluent D562 cells with viruses for 3 d, the viral sus-
pension (or un-inoculated media for mock-infected
controls) was removed from the monolayer and the cells
were washed twice with PBS with 0.2% BSA. Subsets of
the monolayers (both mock and virus-infected) were
inoculated with 1 ml of pneumococcal TIGR4 strain
suspension containing 107 bacteria, and the remaining
monolayers were mock-infected with EMEM. All mono-
layers were incubated for 2 h at 37°C in a 5% CO2 incuba-
tor then washed 2X with PBS with 0.2% BSA. D562 cells
were detached by treatment with 0.025% trypsin-EDTA
(Gibco Laboratories, Grand Island, NY, USA), and cell
clumps were disrupted by gently pipetting up and down.
The cells were collected by centrifugation at 800 x g for
5 min and immediately placed into 5 vol of RNAlater
(Ambion, Austin, TX, USA) to minimize RNA degrad-
ation. Samples were stored at 4°C overnight to allow
RNAlater solution to thoroughly penetrate the cells.
The supernatant was then removed and the pellet was
stored at −80°C until further processing.
RNA preparation
Total RNA was isolated from: (a) RNA-stabilized bacteria
adherent to either mock- or virus-infected D562 cells andbacteria growing freely in EMEM and (b) monolayers of
D562 cells either mock-infected or infected with RSV or
HPIV3. RNA was extracted using TRIzol (Invitrogen
Life Technologies, Carlsbad, CA, USA) in a lysing matrix
containing silica beads on a FastPrep Instrument (MP
Biomedicals, Solon, OH, USA) according to the manu-
facturer’s protocol. RNA was purified with the RNeasy
Mini Kit (Qiagen, Valencia, CA, USA) and the quality
was assessed using the prokaryote and eukaryote total
RNA chips on the Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA).
Microarray experiments
Bacterial microarray experiments were performed on
version 6 S. pneumoniae DNA microarrays distributed
by the Pathogen Functional Genomics Resource Center
(PFGRC, J. Craig Venter Institute, Rockville, MD, USA)
and consisted of 70-mer oligonucleotides representing
open reading frames (ORFs) from the genomes of three
strains: TIGR4, G54 and R6, as well as 10 amplicons and
500 70-mer oligonucleotides from Arabidopsis thaliana,
which served as negative controls. The experiments were
performed as previously described [30]. For analysis of
the human host cell response, microarrays with PCR
amplicons of 41,000 cDNA clones were used (kindly pro-
vided by Norman Lee at George Washington University,
Washington, DC, USA). Preparation of labeled cDNA tar-
get and hybridization experiments were done as previously
described [30] with the exception that for the human
host cell response, the starting amount of RNA used to
synthesize cDNA was 5 μg. Total RNA was isolated
from 3 independent cultures (biological replicates) of
TIGR4 strain and D562 cells. Dye-swap experiments
(technical replicates) were also performed on each bio-
logical replicate.
Data normalization and analysis
Data were analyzed using the TM4 microarray software
suite [31]. Spot intensities were quantified using Spotfinder
v3.1.1. Normalization was performed using the iterative
log mean centering algorithm implemented in the MIDAS
software (v2.19), and the fluorescence ratios were calcu-
lated from the normalized values. Data from the inde-
pendent replicate experiments (only where n ≥ 15) were
averaged using locally developed Perl scripts and the
resultant averages used for clustering algorithms to
check for similar patterns in gene expression. Hierarchical
clustering (HCL) using average linkage and Euclidean
distance was also performed on the data to check for
variability across replicate slides. To determine whether
the observed ratio changes in expression of genes were
both statistically and biologically significant, we applied
the double filter of: (a) a statistical test, significance ana-
lysis of microarrays (SAM) and (b) a threshold ratio of
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SAM analysis, a Δ value of 1.18 was used for TIGR4
in contact with mock-infected and Δ = 2.158 for TIGR4 in
contact with viral-infected cells. This Δ cutoff corre-
sponded to a false positive rate of 0%. We also included
into the final analysis all statistically significant genes
that did not meet the threshold value but appeared to
be co-regulated with one of our identified genes as part
of an operon. For analysis of the human host cell re-
sponse to viruses, a less stringent fold change cut-off of
1.5 was used since the overall gene expression changes
were generally lower on the human microarrays.
Validation of human microarray data by qRT-PCR
Reverse transcription was carried out using the QuantiTect
Reverse Transcription Kit (Qiagen, Valencia, CA, USA) in
accordance with the manufacturer’s instructions. Briefly,
1 μg of total RNA was incubated in gDNA Wipeout Buffer
(7X) and RNase-free water and incubated at 42°C for 2 min
to remove contaminating genomic DNA. The cDNA was
synthesized from the RNA using Quantiscript reverse
transcriptase (RT), Quantiscript RT buffer (5X), and a
primer mix at 42°C for 15 min and then at 95°C for
3 min to inactivate the Quantiscript RT. Dilutions of the
cDNA (0.25 μl of the above mixture per 20 μl reaction)
were used as template in a reaction containing 2X
QuantiTect SYBR Green mix (Qiagen, Valencia, CA, USA),
RNase-free water and gene-specific primers (Additional
file 1: Table S1). The qRT-PCR assays were conducted
using an ABI 7900HT instrument (Applied Biosystems,
Carlsbad, CA, USA). The reactions were denatured at
95°C for 15 min followed by amplification with 45 cycles
of 94°C for 15 s, 55°C for 30 s and 72°C for 30 s. Data was
analyzed using a comparative cycle threshold (ΔCt) method
[32]. The ΔCt was normalized to a gene (NG_007992 -
actin gene) that did not exhibit any significant change in
expression as identified by the microarray experiments.
Each sample was tested in triplicate.
A similar procedure was used for qRT-PCR validation
of pneumococcal microarray data. The primers used are
listed in Additional file 1: Table S2.
Results
Effect of RSV and HPIV3 infection on the adherence of
S. pneumoniae to human pharyngeal cells
D562 cells were permissive to infection with RSV and
HPIV3, with discrete cytopathic effect (CPE) after 72 h
but without much detachment of the monolayers hence
allowing for pneumococcal adherence. We then investi-
gated whether pneumococci adhered in greater numbers
to virus-infected D562 cells than to mock-infected cells.
The optimal incubation period of virus-infected cells re-
quired for maximum bacterial adherence was determined
to be 72 h in a preliminary time-course experiment (datanot shown). The adherence of pneumococcal strains
TIGR4 and G54 to D562 cells increased significantly with
prior viral infection (p < 0.05) (Figure 1). The degree of
enhanced attachment ranged from 1.3- to 2-fold and was
dependent on the dose of initial viral infection. Maximal
adherence due to RSV infection was obtained at a viral
titer of 6.5 × 105 TCID50/ml, and maximal adherence to
HPIV3 was obtained at a viral titer of 8.3 × 103 TCID50/ml.
This influence of viral dose on bacterial adherence was
similar for both pneumococcal strains, although the strains
varied markedly in their baseline adherence capacity
without viral infection (Figure 1).
Gene expression patterns of S. pneumoniae in contact with
either virus- or mock-infected human pharyngeal cells
To limit the number of variables being compared for the
gene expression analysis, we restricted the experiments
to one strain of pneumococcus, TIGR4, and one respira-
tory virus – HPIV3. RNA was isolated from TIGR4 in
contact with HPIV3- or mock-infected D562 cells.
Compared to controls (pneumococci in cell culture
medium), the gene regulation ratios for pneumococci
in contact with virus- or mock-infected pharyngeal cells
varied from 0.1 to 14.4. Among the 77 genes that were
up-regulated, 51 were regulated in both virus-infected and
mock-infected conditions (Additional file 1: Table S3).
These included genes involved in adhesive functions
(psaA, pilus islet), choline uptake and incorporation (lic
operon), transport and binding (SP_1855-SP_1857) and
fatty acid metabolism (SP_0421-SP_0427). The most
highly represented genes were those coding for hypo-
thetical proteins (25%), some of which are putative
membrane proteins. Of the 98 down-regulated pneumo-
coccal genes, 62 were down-regulated in both virus-
infected and mock-infected conditions and these included
choline transporters (proWX, proV) and purine biosyn-
thesis genes (pur operon) (Additional file 1: Table S3).
Among these 51 up-regulated and 62 down-regulated
genes, the degree of regulation was remarkably consist-
ent in the two adherence conditions (Additional file 1:
Figure S1). These genes underpin the common set of cell
functions that are induced by exposure to pharyngeal
cells – regardless of whether those cells are viral-infected.
Eight pneumococcal genes appeared in the list of genes
that were up-regulated after contact with HPIV3-infected
cells but were absent in the list of genes up-regulated
after contact with mock-infected cells. These were: glnQ,
a fibronectin-binding/glutamine transport gene, SP_0204-
SP_0206, ribonucleotide reductase genes, SP_1428 and
SP_2005, genes encoding hypothetical proteins, and
SP_1765-SP_1767, glycosyl transferase genes. Upon fur-
ther examination, we found that these genes were
absent from the list of genes up-regulated by TIGR4
in contact with mock-infected cells because they did
Figure 1 Binding of S. pneumoniae TIGR4 and G54 to D562 cells infected with HPIV3 (A) or RSV (B). The number of bacteria adhering to
mock-infected cells (gray) and to viral-infected cells (black) is shown. The number of bacteria is calculated as the mean (± SEM) number of colony
forming units observed in at least 3 replicate wells. Adhesion of pneumococci to viral-infected cells vs. mock-infected at varying viral doses is
noted with a star (p < 0.05, Student’s test). Since the primary comparison in this figure is between mock-infected and virus-infected cells, the Y-axis
scales for the two bacterial strains are different.
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Methods). We used qRT-PCR to verify the expression
levels of these genes in both conditions, adherence to
HPIV3-infected and mock-infected cells. The 8 genes
had comparable Ct values between the two conditions.
Eighteen genes, all encoding hypothetical proteins, were
up-regulated by TIGR4 in contact with mock-infected
cells only. It is likely that the expression of these 18
genes is inhibited by the viral infection.Effect of HPIV3 and RSV on the expression of human cell
adhesion molecules
Given the very large number of human genes and the
particular hypothesis under test in this study, we focused
our analysis on genes encoding cell adhesion molecules.
HPIV3 infection induced the up-regulation of 55 human
genes (Table 1A). Four of these were also up-regulated
in RSV-infected cells (Table 1 panels A and B, CD47,
AADACL1, ZC3HAV1 and cIAP2, an apoptosis inhibitor).
Other genes that were up-regulated by HPIV3-infected
cells included interferon stimulated genes (ISGs), plas-
minogen activator urokinase (PLAU), collagen type XVII
alpha 1, claudin 1, laminin alpha 3, matrix metallopeptidase
14, and molecules of the carcinoembryonic antigen-related
cell adhesion molecules (CEACAM1). Infection with RSV
induced the up-regulation of 20 genes, including proteins
of the zinc finger family (ZNF23, ZNF318), protocadherin
beta 19, Rho family GTPase 1, fibronectin type III domain
containing protein, and caspase 10.Since the results above suggested that the enhanced ex-
pression of various adhesion molecules following HPIV3
and RSV infection may increase the level of adherence of
pneumococci, we sought to describe the transcription pro-
files of cell adhesion molecules exposed to the TIGR4
strain and compared them to the virus-induced transcrip-
tion profiles. We found that genes that were regulated in
the presence of HPIV3 and RSV were not significantly
regulated in TIGR4; rather, infection with TIGR4 alone
resulted in the up-regulation of a unique set of genes
(Table 1C) which included selenium-binding protein 1
(SELENBP1), granulocyte colony stimulating factor re-
ceptor (CSF3R), and ADAM metallopeptidases. We also
analyzed the transcription of host cells exposed to con-
current stimulation by both viral and bacterial patho-
gens and found that infection of D562 cells with HPIV3
or RSV followed by TIGR4 induced a similar response
to that of infection with HPIV3 or RSV only (Table 1
panels A, B and C).Confirmation of microarray results by qRT-PCR
A subset of differentially expressed genes from the human
microarray experiments was selected and qRT-PCR ana-
lysis was undertaken to confirm the relative levels of gene
expression. The experiments were performed on the same
RNA samples used in microarray experiments. The correl-
ation coefficient (R) between qRT-PCR and microarray
results for pneumococcal transcription in contact with
either virus-infected or mock-infected epithelial cells was
Table 1 Differential expression of cell adhesion molecules
A. Genes up-regulated by infection with HPIV3
Fold change












AA406020 ISG15 ubiquitin-like modifier ISG15 23.80 1.10 1.05 24.76 1.15
AA456886 Myxovirus (influenza virus) resistance 1, interferon-inducible
protein p78
MX1 23.68 1.11 1.04 16.12 1.12
AA286908 Myxovirus (influenza virus) resistance 2 MX2 13.84 1.06 1.05 12.35 1.04
T95113 Radical S-adenosyl methionine domain containing 2 RSAD2 11.72 0.90 1.11 4.49 1.39
AA126958 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 DDX58 11.55 1.16 0.88 9.94 0.96
AA419251 Interferon induced transmembrane protein 1 (9-27) IFITM1 7.32 0.96 0.99 5.88 0.76
AA421603 SAM domain and HD domain 1 SAMHD1 5.67 0.96 0.89 4.80 0.86
AI245550 Phospholipid scramblase 1 PLSCR1 5.00 0.91 0.95 3.36 1.11
AA995904 TCF3 (E2A) fusion partner TFPT 4.05 1.35 1.05 4.12 0.91
AA827287 Interferon-induced protein 35 IFI35 3.85 1.10 0.95 3.40 1.00
H54629 Tumor necrosis factor (ligand) superfamily, member 10 TNFSF10 3.64 NA 1.18 4.32 NA
AA862371 Interferon induced transmembrane protein 2 (1-8D) IFITM2 3.37 0.85 0.92 2.18 0.93
AA877255 Interferon regulatory factor 7 IRF7 3.25 X 1.06 2.13 0.71
R07870 Baculoviral IAP repeat-containing 3; inhibitor of apoptosis
protein
- 3.09 2.09 1.20 1.79 1.60
AI038270 Eukaryotic translation initiation factor 2-alpha kinase 2 EIF2AK2 2.91 1.11 0.99 1.56 1.04
AA479795 Interferon stimulated exonuclease gene 20kda ISG20 2.91 NA 1.10 2.29 NA
N67034 Interferon-induced protein 44-like IFI44L 2.87 1.01 1.05 2.90 0.94
AA418724 Zinc finger CCCH-type, antiviral 1 ZC3HAV1 2.82 1.53 1.31 1.77 1.49
N75384 Peroxisome proliferator-activated receptor gamma, coactivator
1 beta
PPARGC1B 2.45 0.78 0.94 NA 0.58
W37864 Phosphatase and tensin homolog PTEN 2.43 0.90 0.93 1.05 0.78
H17861 Ring finger protein 213 RNF213 2.26 1.05 1.03 1.14 1.02
AA983252 Signal transducer and activator of transcription 2, 113kda STAT2 2.23 X 1.12 1.53 NA
R70479 Tumor necrosis factor, alpha-induced protein 3 TNFAIP3 2.17 0.75 1.03 NA 0.73
AA128561 Collagen, type XVII, alpha 1 COL17A1 1.95 1.11 1.99 1.16 1.15
AI016022 NLR family, CARD domain containing 5 NLRC5 1.93 X X X 0.94
N70463 B-cell translocation gene 1, anti-proliferative BTG1 1.90 1.43 1.13 NA 1.39
H61758 ELK4, ETS-domain protein (SRF accessory protein 1) ELK4 1.86 0.80 0.87 NA 1.03






















Table 1 Differential expression of cell adhesion molecules (Continued)
AI085559 Arylacetamide deacetylase-like 1 AADACL1 1.80 1.64 X 1.69 1.79
AA609992 Dehydrogenase/reductase (SDR family) member 9 DHRS9 1.78 1.45 0.95 1.09 1.50
AA136060 Polycomb group ring finger 5 PCGF5 1.74 0.99 0.96 1.21 0.82
AI364513 Scavenger receptor class B, member 2 SCARB2 1.72 1.06 NA NA 0.97
AA491191 Interferon, gamma-inducible protein 16 IFI16 1.72 1.38 0.94 0.97 1.99
AA451844 Microtubule associated monoxygenase, calponin and LIM
domain containing 2
MICAL2 1.70 0.91 0.91 X 0.79
R92801 CD47 molecule CD47 1.68 1.57 1.01 1.16 1.64
R93911 Glycogen synthase kinase 3 beta GSK3B 1.68 1.29 NA NA 1.32
AA776304 Pleckstrin 2 PLEK2 1.67 0.97 NA 1.81 1.08
AA490894 Endoplasmic reticulum aminopeptidase 1 ERAP1 1.67 1.19 0.87 X 1.25
AA777854 Ring finger protein 12 RNF12 1.67 0.85 0.99 NA 0.92
AA040699 ELK3, ETS-domain protein (SRF accessory protein 2) ELK3 1.65 0.99 0.91 X 0.86
H95362 Claudin 1 CLDN1 1.64 0.83 NA 1.26 1.20
AA411757 Carcinoembryonic antigen-related cell adhesion molecule 1
(biliary glycoprotein)
CEACAM1 1.63 X NA 1.41 0.51
AA284668 Plasminogen activator, urokinase PLAU 1.63 1.15 1.27 X 1.25
AA135422 CCR4-NOT transcription complex, subunit 1 CNOT1 1.63 0.99 0.89 1.04 1.05
AI049712 Epidermal growth factor receptor EGFR 1.62 1.00 0.91 1.13 0.96
N70848 Ring finger protein 141 RNF141 1.58 1.11 0.94 1.08 0.90
AA005112 LIM domain 7 LMO7 1.58 0.89 0.83 0.81 0.77
AA488674 Myeloid cell leukemia sequence 1 (BCL2-related) MCL1 1.58 0.96 X X 0.84
AA018412 Coiled-coil domain containing 93 CCDC93 1.57 0.92 1.11 1.03 0.85
AA478738 Catenin, beta interacting protein 1 CTNNBIP1 1.55 0.97 0.88 X 1.03
AI652954 Transglutaminase 1 (K polypeptide epidermal type I, protein-
glutamine-gamma-glutamyltransferase)
TGM1 1.54 0.67 0.86 1.05 0.56
N59721 Serpin peptidase inhibitor, clade E (nexin, plasminogen
activator inhibitor type 1), member 2
SERPINE2 1.54 0.69 0.88 X 0.93
AA001432 Laminin, alpha 3 LAMA3 1.53 1.23 0.86 0.94 1.21
AA706099 NEDD4 binding protein 1 N4BP1 1.52 1.08 1.01 1.19 0.98
N33214 Matrix metallopeptidase 14 (membrane-inserted) MMP14 1.52 0.84 0.79 1.26 0.91
B. Genes up-regulated by infection with RSV
AA406373 Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) TAP2 1.46 2.28 1.10 1.18 1.27






















Table 1 Differential expression of cell adhesion molecules (Continued)
R07870 Baculoviral IAP repeat-containing 3; inhibitor of apoptosis
protein
- 3.09 2.09 1.20 1.79 1.60
AA701353 Hypothetical protein LOC92270 LOC92270 0.79 2.07 0.90 1.34 2.45
AA001983 Hypothetical LOC92482 LOC92482 0.83 1.74 1.08 NA X
AI014782 Trinucleotide repeat containing 6B TNRC6B 1.22 1.99 1.08 0.86 1.88
H80712 Caspase 10, apoptosis-related cysteine peptidase CASP10 X 1.73 0.79 X 1.84
H23077 Rho family GTPase 1 RND1 X 1.71 X NA 1.75
AA903644 Protocadherin beta 19 pseudogene PCDHB19P 0.84 1.65 X X 1.67
AI085559 Arylacetamide deacetylase-like 1 AADACL1 1.80 1.64 NA 1.69 1.79
H01197 Pleckstrin homology domain containing, family F (with FYVE
domain) member 2
PLEKHF2 0.96 1.63 0.87 0.87 1.35
R36431 Fibronectin type III domain containing 3A FNDC3A 1.37 1.62 0.92 1.03 1.41
AA047413 Zinc finger protein 23 (KOX 16) ZNF23 NA 1.60 1.18 X 1.20
AA903552 Lysozyme-like 1, lysozyme-like 2 LYZL1,
LYZL2
X 1.58 NA NA 1.79
AA485438 Ring finger protein 187 RNF187 0.84 1.58 1.02 0.86 1.18
R92801 CD47 molecule CD47 1.68 1.57 1.01 1.16 1.64
AI168153 Pleckstrin homology domain containing, family A
(phosphoinositide binding specific) member 8
PLEKHA8 X 1.57 X X 1.41
AA878257 Colony stimulating factor 1 CSF1 X 1.57 NA NA 1.13
AA418724 Zinc finger CCCH-type, antiviral 1 ZC3HAV1 2.82 1.53 1.31 1.77 1.49
AI004484 Zinc finger protein 318 ZNF318 X 1.52 1.29 NA 1.62
C. Genes up-regulated by infection with TIGR4
T65736 Selenium-binding protein SELENBP1 3.98 0.65 1.35 1.12 NA
AI093729 ADAM metallopeptidase with thrombospondin type 1 motif, 2 ADAMTS2 3.87 1.61 1.59 0.59 NA
AA443000 Granulocyte colony stimulating factor receptor CSF3R 2.75 1.43 0.89 1.10 0.93
AA460304 Human ribosomal DNA complete repeating unit CRISPLD2 2.58 NA 1.27 NA 0.75
AI003033 Neural cell adhesion molecule 2 NCAM2 2.56 1.50 1.43 1.36 0.97
AA904923 HNF1 homeobox B HNF1B 2.34 0.65 1.40 NA 1.30
AA521362 CR2/CD21/c3d/Epstein-Barr virus receptor complement
component receptor 2
CR2 2.33 NA 1.15 NA 0.99
T98262 General transcription factor IIIC, polypeptide 3 GTF3C3 2.33 0.96 1.50 NA 0.72
AA904604 RIKEN LOC143678 2.21 1.11 0.80 1.46 0.95






















Table 1 Differential expression of cell adhesion molecules (Continued)
W60968 Myelin protein zero-like protein2; Epithelial V-like antigen 1
precursor
MPZL2 2.19 NA 2.47 NA 0.36
R88767 Protocadherin 10; protocadherin 20 precursor PCDH20 2.13 0.72 1.34 NA 0.81
R01281 Src kinase-associated phosphoprotein1; SKAP55 protein SKAP55 1.94 NA 1.22 NA 1.17
AA150694 LY6/PLAUR domain containing 6 LYPD6 1.85 NA 1.26 NA 1.08
AA707615 Chromosome 9 open reading frame 116 C9orf116 1.83 0.73 1.05 NA 0.87
H57180 Phospholipase C-like phospholipase C, gamma 2
(phosphatidylinositol-specific)
PLCG2 1.82 NA 1.23 NA 1.09
AA883775 Metallaproteinase-disintegrin ADAM30 1.80 0.32 1.19 NA 2.26
AI361560 Homeo box C9 HOXC9 1.76 0.59 0.91 0.89 0.93
AI380234 C1qr(p) complement component C1q receptor CD93 1.76 0.55 NA 0.56 NA
R86733 Zinc finger protein ZNF397 1.74 NA 1.59 NA 1.10
R08109 Alu subfamily J sequence contamination warning entry ZNF398 1.70 1.02 0.96 0.81 1.05
AA176413 F-box protein Fbx20 FBX20 1.70 0.36 1.08 NA 1.09
H90292 Procollagen type V alpha 2 SERPINA1 1.70 1.77 0.94 1.47 0.76
AA680249 Bactericidal/permeability-increasing protein BPI 1.69 1.20 2.06 1.24 NA
R43755 Intraflagellar transport protein 57 homolog ESRRBL1 1.68 1.35 1.28 0.97 1.05
AA620742 Xenotropic and polytropic retrovirus receptor XPR1 1.67 1.37 0.87 0.82 1.00
AA137073 Integrin, beta-like 1 (with EGF-like repeat domains) ITGBL1 1.66 0.81 1.03 0.74 0.99
T70368 Integrin, beta 5 ITGB5 1.66 1.03 1.09 1.64 1.01
R76099 Toll-like receptor 3 TLR3 1.62 0.58 0.83 NA 0.85
H52352 Complement factor properdin CFP 1.62 NA 1.54 NA 0.54
R98903 Scavenger receptor class B, member 1 SCARB1 1.59 NA 1.01 NA 0.73
AA150507 Interleukin 1, beta IL1B 1.59 1.99 1.81 1.17 0.56
T98612 Alpha-1 type III collagen COL3A1 1.57 1.74 0.83 NA 1.06
T52330 Interleukin 6 receptor IL6R 1.57 1.36 1.06 1.07 1.17
AA010600 Nuclear RNA export factor 3 NXF3 1.56 1.58 1.23 0.99 1.00
AA176249 Transforming growth factor, beta 2 TGFB2 1.56 0.64 0.87 NA 1.18
R10099 Stabilin-2 STAB2 1.56 0.98 1.10 1.18 1.21
N32241 Zinc finger protein 160 ZNF160 1.55 NA 1.10 NA 1.06
W94121 Tumor necrosis factor receptor superfamily, member 19 TNFRSF19 1.55 1.17 1.06 0.53 0.92
H93115 Ras association (ralgds/AF-6) and pleckstrin homology domains 1 RAPH1 1.54 1.56 0.72 0.80 NA
AA455067 Non-Ab component of amyloid peptide precursor SNCA 1.54 NA 1.14 NA 0.93






















Table 1 Differential expression of cell adhesion molecules (Continued)
AA456622 Wiskott-Aldrich syndrome protein interacting protein WIPF1 1.54 NA 1.16 NA 1.00
H74265 Protein tyrosine phosphatase, receptor type, C PTPRC 1.53 NA 1.15 NA 1.20
T68892 Secreted apoptosis related protein 2 SFRP1 1.52 NA 0.95 1.17 1.16
AA780815 Alpha-2 type VIII collagen COL8A2 1.50 0.98 1.14 1.43 0.83
Genes listed are up-regulated by infection with HPIV3 (A), RSV (B), and/or TIGR4 (C).
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ation coefficient between the two conditions in HPIV-3
infected cells and RSV-infected cells were 0.87 and 0.65,
respectively (Additional file 1: Figure S2).
Discussion
Binding of pneumococci to virus-infected cells
In the present study, we have used a well-established
model of adherence to demonstrate that infection of
human pharyngeal cells with paramyxoviruses RSV or
HPIV3 enhanced the adherence of S. pneumoniae strains
TIGR4 and G54. While this finding is consistent with
the results of other in vitro studies [21,33-35], this is
the first report of RSV and HPIV3 increasing the in vitro
adherence of S. pneumoniae to human pharyngeal cells
(Detroit 562). The enhanced adherence of bacteria to
virus-infected cells was consistent across both viruses
and pneumococcal strains/serotypes evaluated. HPIV3
and RSV were used in this study as they are among the
viruses most commonly predisposing to secondary bac-
terial infections [36,37]. The results also show that
both the neuraminidase (NA)-positive (HPIV3) and NA-
negative (RSV) viruses enhanced binding of pneumococci
to pharyngeal cells. Viral neuraminidase cleaves terminal
sialic acid on eukaryotic cells, unmasking receptors that
facilitate pneumococcal adherence [38]. This suggests
that NA-enhanced bacterial adherence is not the only
mechanism for increased bacterial adherence following
viral infection.
Mechanism of viral/bacterial synergy: a bacterial
standpoint
We wanted to determine whether: (i) the pneumococcus
is capable of detecting and responding to the host cell
changes by expressing additional factors to complement
newly expressed host cell receptors on the surface of
viral-infected cells, or (ii) S. pneumoniae simply ex-
presses the same baseline set of genes in response to
contact with host cell regardless of the status of viral in-
fection. In the latter case, the advantage of viral infection
to pneumococcal adherence would be determined entirely
by the viral effect on human cells. Our results demon-
strate that there is a common set of pneumococcal genes
that participate in the induction of adherence regardless
of the presence of a virus. We believe that this study is the
first to analyze the reciprocal response of S. pneumoniae
to viral infection at a global transcriptome level.
As enhanced adherence was observed with both pneu-
mococcal strains and with both viruses, we focused the
pneumococcal microarray experiments on one strain–virus
combination. We selected TIGR4 because it exhibited
greater adherence to epithelial cells than G54, and we
selected HPIV3 because it expresses NA. Our observa-
tion that multiple pneumococcal adhesins are regulatedupon the binding of the bacterium to both mock- and
virus-infected cells suggests that there is a common set
of genes whose protein products represent good targets
for designing interventions to prevent pneumococcal in-
fection in the nasopharynx.
The up-regulated operon SP_0204–SP_0206 encodes
a ribonucleoside triphosphate reductase (nrdD) and its
activating protein (nrdG). This operon is active during
anaerobic conditions [39,40] and in many bacterial species,
the operon is up-regulated to enable bacteria to survive
during oxidative stress [39]. The gene nrdG has been
shown to be up-regulated in S. pneumoniae during
infection of blood and meninges [41]. Human cells infected
with viruses generate a large amount of inflammatory
products and therefore up-regulation of this operon in the
pneumococcus suggests the existence of oxygen tension.
This is a plausible explanation of how the pneumococcus
is able to resist this stressful environment and in the end
confer the phenotype of enhanced adherence. McCullers
and colleagues have proposed that fibrin and fibrinogen,
deposited during the regenerative process following viral
infection, may provide additional attachment sites for
bacteria [2]. It was therefore interesting to observe that
glnQ (SP_1242), a gene previously shown to be required
for adherence to fibronectin by group B Streptococcus
[42] was significantly up-regulated in TIGR4 in contact
with virus-infected cells. It is possible that it might have
a specific adhesive function in S. pneumoniae on contact
with virus-infected epithelial cells.
Mechanism of viral/bacterial synergy: a host standpoint
We hypothesized that viral infection can enhance bacterial
adhesion by increasing the expression of host cell recep-
tors. Our study supported this contention by showing that
a variety of epithelial cell receptors (CEACAM1, CD47,
interferon-stimulated genes, among others) were up-
regulated in response to HPIV3 and RSV infection. Other
studies examining this question have either focused exclu-
sively on the expression of a small number of cell adhe-
sion receptors, or have studied non-human epithelial cells.
CEACAM1 and CD47 have previously been identified
in the host cell response to viral infection [21] and we
have confirmed this observation with regard to HPIV3.
CEACAM1 binds meningococcal and gonococcal opacity-
associated (Opa) proteins and mediates internalization
of the bacteria into several cell types in vitro [43]. It also
binds to Haemophilus influenzae and Moraxella catarrhalis,
which share their ecological niche with S. pneumoniae.
Though the CEACAM-binding adhesins in S. pneumoniae
are unknown, if they exist, the fact that CEACAM1 is
one of a small number of genes up-regulated after viral
infection suggests that this may be an area for future
study. CD47, a gene encoding an integrin-associated pro-
tein, was up-regulated in response to infection by both
Kimaro Mlacha et al. BMC Genomics 2013, 14:378 Page 12 of 14
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previously been shown to render mice susceptible to
E. coli K1 meningitis [44].
Interestingly, the gene encoding a fibronectin type III
domain-containing protein was up-regulated by the host
in response to both viruses (significantly in RSV and
moderately in HPIV3). In our pneumococcal gene ex-
pression studies, a fibronectin-binding gene, glnQ was
highly up-regulated in TIGR4 in contact with virus-
infected cells. The symmetry of these observations sug-
gests that virus-induced up-regulation of fibronectin type
III induced a reciprocal response in S. pneumoniae in the
form of up-regulation of a ligand to match the newly
up-regulated host receptor. This is a specific hypothesis
worth pursuing in future functional experiments.
Other genes that were significantly up-regulated in our
study include several interferon-stimulated genes (ISGs)
and the urokinase plasminogen activator (PLAU), which
mediates a response to the inflammation induced by the
virus. Induction of ISGs and NOD-like receptor family
(Table 1) in our study is consistent with a recent finding
that the cross-talk between Nod1/Nod2 receptors and
type 1 IFNs induced during a viral infection, promoted
lethality in mice superinfected with E. coli [45]. Up-
regulation of genes encoding a matrix metalloproteinase,
MMP14 and also caspase 10 may provide a mechanism
by which the viruses induce lysis of the host cell compo-
nents and, in the process, facilitate increased adherence
and possibly invasion of bacteria.
Conclusions
In summary, we have shown that: (a) D562 cells were
permissive to RSV and HPIV3; (b) these viruses aug-
mented the adherence of S. pneumoniae to the host cells
by a factor of 1.3-2.0; (c) infection with both RSV and
HPIV3 enhanced the transcription of host cell adhesion
molecules that facilitate or mediate bacterial adhesion in
general; and (d) there is a core transcriptome (at least in
the TIGR4 strain) that represents the basic machinery
required for adherence of pneumococci to D562 cells
regardless of whether the cell is infected with a virus or
not. Further elucidation of these mechanisms is most
likely to be obtained by specific inhibition of the expres-
sion of the host cell receptors or by bacterial gene knock-
out experiments.
Additional file
Additional file 1: Table S1. is a table listing the primers used for qRT-
PCR analysis of human genes. Table S2. is a table listing the primers
used for qRT-PCR analysis of pneumococcal genes. Table S3. is a table
listing genes commonly significantly regulated by TIGR4 in contact with
either viral- or mock-infected human pharyngeal cells. Figure S1. is a
figure depicting the correlation of the log2 ratios of TIGR4 adherent to
mock-infected cells and to HIPV3-infected cells. Figure S2. is a figureshowing graphs of qRT-PCR validation of human and pneumococcal
microarray results.
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